Codexis Inc (CDXS)

Nov 26, 2024

Cantor Fitzgerald Reaffirms “Overweight” Rating for Codexis (NASDAQ:CDXS) - Defense World

Nov 26, 2024

Nov 26, 2024

Codexis's SWOT analysis: enzymatic platform poised to shake up RNAi stock - Investing.com

Nov 26, 2024

Nov 23, 2024

Codexis (NASDAQ:CDXS) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat

Nov 23, 2024

Nov 22, 2024

Deep Dive Into Codexis Stock: Analyst Perspectives (4 Ratings) - Benzinga

Nov 22, 2024

Nov 22, 2024

Codexis (STU:4QK) EBITDA per Share : €-0.40 (TTM As of Sep. 2024) - GuruFocus.com

Nov 22, 2024

Nov 21, 2024

Codexis (STU:4QK) 3-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024

Nov 21, 2024

Codexis (STU:4QK) 3-Year FCF Growth Rate : -35.00% (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024

Nov 20, 2024

Codexis (STU:4QK) Forward Dividend Yield % : 0.00% (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024

Nov 20, 2024

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire

Nov 20, 2024

Nov 19, 2024

Codexis to Present at Piper Sandler Healthcare Conference in December 2024 | CDXS Stock News - StockTitan

Nov 19, 2024

Nov 15, 2024

Codexis (NASDAQ:CDXS) Given Overweight Rating at Cantor Fitzgerald - MarketBeat

Nov 15, 2024

Nov 14, 2024

Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics - GlobeNewswire

Nov 14, 2024

Nov 14, 2024

Codexis Achieves 98% Efficiency in Breakthrough siRNA Synthesis Platform | CDXS Stock News - StockTitan

Nov 14, 2024

Nov 14, 2024

Baillie Gifford & Co. Sells 895,002 Shares of Codexis, Inc. (NASDAQ:CDXS) - MarketBeat

Nov 14, 2024

Nov 12, 2024

Codexis adds biotech veteran Raymond De Vré to board - Investing.com India

Nov 12, 2024

Nov 12, 2024

Codexis Strengthens Board and Updates Bylaws - TipRanks

Nov 12, 2024

Nov 12, 2024

CDXSCodexis, Inc. Latest Stock News & Market Updates - StockTitan

Nov 12, 2024

Nov 12, 2024

Codexis adds biotech veteran Raymond De Vré to board By Investing.com - Investing.com UK

Nov 12, 2024

Nov 12, 2024

Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

Codexis Strengthens Board with Biotech Veteran Raymond De Vré, Former PolyPeptide CEO | CDXS Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

Biofuel Enzymes Market Growth Surge: Key Players and Market - openPR

Nov 12, 2024

Nov 11, 2024

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics - GlobeNewswire

Nov 11, 2024

Nov 11, 2024

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for - The Bakersfield Californian

Nov 11, 2024

Nov 11, 2024

Codexis to Showcase Breakthrough RNA Platform, Partners with Bachem at TIDES Europe 2024 | CDXS Stock News - StockTitan

Nov 11, 2024

Nov 08, 2024

Codexis Announces New Employment Inducement Grants - The Manila Times

Nov 08, 2024

Nov 07, 2024

Codexis, Inc.'s (NASDAQ:CDXS) 29% Jump Shows Its Popularity With Investors - Simply Wall St

Nov 07, 2024

Nov 06, 2024

Benchmark Downgrades Codexis (CDXS) - MSN

Nov 06, 2024

Nov 06, 2024

CDXS (Codexis) PE Ratio : At Loss (As of Nov. 06, 2024) - GuruFocus.com

Nov 06, 2024

Nov 06, 2024

Codexis (FRA:4QK) 3-Year EBITDA Growth Rate : -26.40% (As of Sep. 2024) - GuruFocus.com

Nov 06, 2024

Nov 06, 2024

Benchmark Reaffirms “Hold” Rating for Codexis (NASDAQ:CDXS) - Defense World

Nov 06, 2024

Nov 06, 2024

Codexis's SWOT analysis: enzyme engineering firm pivots to RNAi stock By Investing.com - Investing.com Australia

Nov 06, 2024

Nov 05, 2024

abrdn plc Grows Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat

Nov 05, 2024

Nov 04, 2024

Codexis's SWOT analysis: enzyme engineering firm pivots to RNAi stock - Investing.com India

Nov 04, 2024

Nov 04, 2024

Codexis to Participate in Upcoming Healthcare Conferences - The Manila Times

Nov 04, 2024

Nov 04, 2024

Codexis (NASDAQ:CDXS) Earns Hold Rating from Benchmark - MarketBeat

Nov 04, 2024

Nov 03, 2024

Codexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.17 - Yahoo Finance

Nov 03, 2024

Nov 03, 2024

Codexis, Inc. Announces Strong Third Quarter 2024 Financial Results - Defense World

Nov 03, 2024

Nov 02, 2024

Codexis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Nov 02, 2024

Nov 02, 2024

Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 02, 2024

Nov 02, 2024

Codexis, Inc. (NASDAQ:CDXS) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 02, 2024

Nov 01, 2024

Codexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com

Nov 01, 2024

Nov 01, 2024

Earnings call: Codexis reports revenue growth and strategic focus in Q3 2024 - Investing.com

Nov 01, 2024

Nov 01, 2024

Codexis Inc Q3 2024 Earnings: Revenue Hits $12.83M, Beating Esti - GuruFocus.com

Nov 01, 2024

Nov 01, 2024

Codexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Focus ... - Yahoo Finance

Nov 01, 2024

Nov 01, 2024

Codexis Reports Strong Q3 Revenue Growth - TipRanks

Nov 01, 2024

Oct 31, 2024

Codexis: Q3 Earnings Snapshot - CT Insider

Oct 31, 2024